Related Experiment Videos
Ringer's ethyl pyruvate solution: a novel resuscitation fluid.
1University of Pittsburgh Medical Center, Division of Critical Care Medicine, 3550 Terrace Street, Room 616 Scaife Hall, Pittsburgh, PA 15261, USA. finkmp@anes.upmc.edu
Minerva Anestesiologica
|May 29, 2001
Summary
Reactive oxygen species (ROS) contribute to critical illness. A new solution, Ringer's Ethyl Pyruvate Solution (REPS), uses ethyl pyruvate to scavenge ROS, showing promise in animal models.
Area of Science:
- Biochemistry
- Pathophysiology
- Pharmacology
Background:
- Reactive oxygen species (ROS) are implicated in tissue damage during critical illnesses like sepsis and shock.
- Pyruvate is a potent ROS scavenger but unstable in solution, limiting its therapeutic use.
Purpose of the Study:
- To develop a stable, therapeutic ROS scavenger for critical illness.
- To evaluate the efficacy of a novel ethyl pyruvate-based resuscitation fluid.
Main Methods:
- Developed Ringer's Ethyl Pyruvate Solution (REPS), a stable derivative of pyruvate.
- Tested REPS in animal models of critical illness.
Main Results:
- REPS demonstrated effectiveness in scavenging ROS.
- Preliminary studies showed improved outcomes in animal models of critical illness.
Conclusions:
- Ethyl pyruvate in REPS offers a stable and effective approach to ROS scavenging.
- REPS shows therapeutic potential for critical illness conditions involving oxidative stress.